Pages with the most revisions

Showing below up to 50 results in range #101 to #150.

101. Biotechnology - Genomic and Proteomics/Competitive advantages in BGP (11 revisions)
102. IP Profile of non-profit companies in EM-K12 (11 revisions)
103. Hal Plotkin Interview Notes - August 10, 2009 (11 revisions)
104. ICP Parking Lot/Sustainability (11 revisions)
105. Diagnostic Kits/Priorities for Personalized Medicine (10 revisions)
106. Alternative Energy/Bibliography for Item 6 in AE (10 revisions)
107. Reed Elsevier (10 revisions)
108. Bibliography for Item 12 in BGP (10 revisions)
109. Diagnostic Kits/Patents and the Progress of Personalized Medicine (9 revisions)
110. General Bibliography for EM (9 revisions)
111. Value Chain in Telecommunications (9 revisions)
112. Competitive advantages in EM (9 revisions)
113. NIH Web Based Survey of DNA-Based Patents (9 revisions)
114. Biotechnology - Genomic and Proteomics/IP Profile of Associations in BGP (8 revisions)
115. Diagnostic Kits/IP Profile of Biggest for-profit companies in Kits (8 revisions)
116. Main Page/ICP Complete Bibliography (8 revisions)
117. Economics of Intellectual Property in BGP Bibliography (8 revisions)
118. Alternative Energy/IP Profile of Associations in AE (8 revisions)
119. Alternative Energy/Impacts of Intellectual Property in AE (8 revisions)
120. Diagnostic Kits/The dangers of diagnostic monopolies (8 revisions)
121. History of EM Field (7 revisions)
122. Diagnostic Kits/Biotechnology and Intellectual Property Reinventing the Commons (7 revisions)
123. Diagnostic Kits/IP Profile of non-profit companies in Kits (7 revisions)
124. Diagnostic Kits/The market economy and the scientific commons (7 revisions)
125. Diagnostic Kits/NIH Principles and Guidelines for Sharing of Biomedical Resources (7 revisions)
126. Bibliography for Item 5 in BGP (7 revisions)
127. Florida (7 revisions)
128. IP Profile of Universities working in EM-K12 (6 revisions)
129. Diagnostic Kits/Patent pools and diagnostic testing (6 revisions)
130. Defining the Commons (6 revisions)
131. Bibliography for Item 4 in BGP (6 revisions)
132. Verlagsgruppe Georg von Holtzbrinck (6 revisions)
133. Vaccines/Sara Crager on Vaccines (6 revisions)
134. Katherine Dykes (6 revisions)
135. Diagnostic Kits/Changing Winds For Gene Patenting In the US (6 revisions)
136. The K-12 Level (6 revisions)
137. Biotechnology - Genomic and Proteomics/IP Profile of non-profit companies in BGP (6 revisions)
138. Economics of Intellectual Property in Telecommunications (6 revisions)
139. Harcourt Education (6 revisions)
140. Diagnostic Kits/IP Profile of Associations in Kits (6 revisions)
141. Bibliography for Item 8 in BGP (6 revisions)
142. Bibliography for Item 10 in BGP (6 revisions)
143. Overview of Economics of Intellectual Property in EM-K12 (6 revisions)
144. AE Essay on EFRC Survey/EFRC Resources and Bibliography (6 revisions)
145. Diagnostic Kits/Country Reports Review (5 revisions)
146. Europe Country Report (5 revisions)
147. Neeru Khosla Interview Notes - September 4, 2009 (5 revisions)
148. Ahrash Bissell Interview Notes - May 12, 2009 (5 revisions)
149. Diagnostic Kits/Peer-Production Business models in Kits (5 revisions)
150. Diagnostic Kits/DNA Patenting and Licensing (5 revisions)